Skip to main content

Table 2 Average costs (standard deviation) for each phase of sarcoma management by country (in €, 2009)

From: Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

Phases of treatment

All patients (n = 219)

Rhône-Alpes France (n = 58)

Veneto Italy (n = 161)

Diagnosis

3,701 (7420)

1,392 (1,450)

4,534 (8,484)

Surgery (primary and wide surgical excision)

8,170 (7,364)

9,046 (6,226)

7,855 (7,749)

Chemo-therapy

6,107 (11,988)

9,689 (14,003)

4,815 (11,196)

Radio-therapy

2,270 (5,850)

1,615 (2,495)

2,505 (6,665)

Follow-up

5,048 (11,760)

4,414 (8,864)

5,277 (12,693)

Follow-up without relapse

1,468 (11,760)a

1,732 (1,728)b

1,379 (2,501)c

Follow-up with relapse

16,261 (11,760)d

11,454 (14,745)e

18,339 (21,611)f

Overall management

25,296 (22,919)

26,156 (18,190)

24,986 (24,575)

  1. an = 58; bn = 42; cn = 16; dn = 161; en = 124; fn = 37.